How I Slowed My Ovarian Age (And How You Can Too)
Vorschaubild von YouTube. Abspielen lädt den YouTube-Player.
Verlauf & EmpfehlungenAus
Zuletzt angesehene Inhalte in diesem Browser behalten. Dein Verlauf bleibt auf diesem Gerät und wird nicht an Harbor gesendet. Abgespielte Videos können auch passende Videoempfehlungen sortieren.
Merkliste & Verlauf öffnen →Über dieses Video
Beschreibung des Creators · Originalsprache
For the first time in history, ovarian biological age can be measured, and I became the first woman in the world to take the test.
Until now, women have had no real way to understand how their ovaries are aging beyond rough estimates like AMH. But this new machine-learning algorithm, trained on over 40,000 real women across different life stages, analyzes hormone biomarkers, body composition, and reproductive history to estimate ovarian age relative to chronological age. This is a massive step forward in female longevity science.
In this episode, I walk through what the test measures, how the algorithm works, and what becoming the first data point actually means, not just for me, but for women collectively. We also explore what may be driving ovarian aging in the first place.
I also share how I’m now testing specific interventions in isolation, including hyperbaric oxygen therapy, to determine whether we can meaningfully influence ovarian aging over time.
Ovarian lifespan is significantly shorter than overall lifespan and once we can measure it, we can begin to understand it. This is only the first step in redefining female longevity.
See my full ovarian protocol here: https://www.protocol.kaylabarnes.com/#ovarian
Join the most comprehensive *female-specific community for health and longevity optimization.* After over a decade dedicated to human performance and women’s health, I created this space to share everything you need to know to optimize health and lifespan. Inside, you’ll get access to exclusive protocols, live Q&As, the latest female longevity science, and a private, supportive community of like-minded women.
https://kayla-barnes-lentz.circle.so/female-longevity-community
Chapters:
00:00:00 I Became the First Woman in the World to Test Her Ovarian Age
00:02:25 Why Ovarian Age Matters More Than AMH Alone
00:04:03 My Full Longevity Protocol Recap
00:05:01 Why I’m Isolating Hyperbaric Oxygen
00:07:07 The Hallmarks of Ovarian Aging: A New Framework
00:07:23 Hallmark #1: Mitochondrial Dysfunction
00:10:24 Hallmark #2: Ovarian Tissue Fibrosis & Vascular Health
00:12:25 Hallmark #3: Egg Loss & Rapamycin Research
00:13:50 Hallmark #4: Increased Sympathetic Tone
00:15:20 Hallmark #5: Chronic Inflammation & Oxidative Stress
00:16:13 What You Can Do Today, Environmental Toxins and PFAS
*Kayla's social + website:*
Instagram: https://www.instagram.com/kaylabarnes/
TikTok: https://www.tiktok.com/@femalelongevity
Twitter: https://x.com/femalelongevity
Website: https://www.kaylabarnes.com
Spotify:https://open.spotify.com/show/4OLWWn22RGB0argbRPvAaQ?si=8e91b3c9e0ce4054
Apple:https://podcasts.apple.com/us/podcast/longevity-optimization-with-kayla-barnes-lentz/id1591130227
Follow Her Female Protocol: https://www.protocol.kaylabarnes.com
SHOW NOTES:
00:01:03 Timeless Biotech Website: https://timelessbiotech.com/
00:01:13 Podcast with the Founder of Timeless Biotech: https://www.youtube.com/watch?v=s-_EuNUwjsM&t=57s
00:04:12 Kayla’s Protocols: https://www.protocol.kaylabarnes.com/
00:09:58 Podcast With Dr. Chris Masterjohn: https://www.youtube.com/watch?v=z3quYW_pCDU
00:10:48 Study About Ovarian Stiffness Increase: https://pmc.ncbi.nlm.nih.gov/articles/PMC7681059/#acel13259-sec-0002
00:16:22 Study For Increased PFAS: https://pubmed.ncbi.nlm.nih.gov/41620147/
00:17:56 Red Light Therapy Study: https://www.sciencedirect.com/science/article/abs/pii/S1011134424001842?via=ihub
Kayla Barnes-Lentz · 19 min · Quelle veröffentlicht: 2026-02-14
Zu Harbor hinzugefügt: 22.10.2026
Original auf YouTube ↗Automatisch eingeordnete Quelle. Creator-Aussagen sind keine unabhängige Evidenzprüfung und keine persönliche medizinische Beratung.